Stella Creasy
Labour
Walthamstow
Commons
To ask the Secretary of State for Health and Social Care, whether his Department holds any list of patients who have been identified as immunocompromised and are eligible for new covid-19 treatments first…
This answer is the replacement for a previous holding answer.
Answer
Maggie Throup
Conservative
Erewash
Commons
Answered on
21 March 2022
The Department commissioned an independent expert group to identify clinically eligible patient cohorts most likely to progress towards developing severe COVID-19. These cohorts form part of an evidence-based clinical policy for the treatment of COVID-19, agreed by the United Kingdom Chief Medical Officers. The treatments available include the monoclonal antibody therapy sotrovimab, as well as the oral antiviral treatments molnupiravir and nirmatrelvir + ritonavir.
The Department does not hold a list of these patients, nor any identifiable personal information